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Abstract: Mesenchymal stem cells (MSCs) are undifferentiated cells that have the ability of self-renewal and trans-
differentiation into other cell types. They hold out hope for finding a cure for many diseases. Nevertheless, there are 
still some obstacles that limit their clinical transplantation. One of these obstacles are the xenogeneic substances 
added in either proliferation or differentiation media with subsequent immunogenic and infectious transmission 
problems. In this study, we aimed to replace fetal bovine serum (FBS), the main nutrient source for MSC prolifera-
tion with xeno-free blood derivatives. We tested the effect of human activated pure platelet-rich plasma (P-PRP) and 
advanced platelet-rich fibrin (A-PRF) on the proliferation of human adipose derived-MSCs (AD-MSCs) at different 
concentrations. For the induction of MSC neural differentiation, we used human cerebrospinal fluid (CSF) at differ-
ent concentrations in combination with P-PRP to effect xeno-free/species-specific neuronal/glial differentiation and 
we found that media with 10% CSF and 10% PRP promoted glial differentiation, while media with only 10% PRP 
induced a neuron-like phenotype.
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Introduction
Among the different types and sources of stem 
cells, special attention has been directed to 
adipose-derived mesenchymal stem cells (AD- 
MSCs). Among the reasons are an easier and 
less invasive collection technique than with 
bone marrow, a high in vitro proliferative rate, 
multi-differentiative potentiality, and tissue 
repair properties [6].
Fetal bovine serum (FBS) is the most widely 
applicable cell culture additive to stimulate cell 
proliferation (Jayme, Epstein, and Conrad 
1988), but the safety and suitability of FBS are 
problematic due its high endotoxin content [11] 
and the risk of infection transmission [10]. FBS-
free culture techniques would make in vitro cell 
culture more economical and ethical [52].
Platelet-rich plasma (PRP) is a blood derivative 
that provides a natural cocktail of autologous 
growth factors capable of potentiating stem cell 
proliferation, migration, and differentiation [37, 
67]. Furthermore, it has the ability to up-regu-
late pluripotency markers and down-regulate 
lineage-specific marker expression in human 
MSCs, adipose-derived stem cells, and human 
muscle-derived progenitor cells [30, 31, 45]. 
Additionally PRP can decrease cell death via 
the reduction of expression levels of the Bcl-2-
interacting mediator of cell death (BIM) gene 
and by inhibition of apoptosis [13].
Platelet-rich fibrin (PRF), a second-generation 
platelet concentrate, [8], can be produced sim-
ply without any anticoagulants thereby eliminat-
ing the risk associated with the use of bovine 
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thrombin [43]. Choukroun, a developer of PRF, 
further modified it to an advanced form called ad- 
vanced PRF (A-PRF) [15] which released signifi-
cantly higher total quantities of growth factors 
compared to traditional PRF [25].
It has been reported that in vitro differentiation 
of MSCs into neural precursor cells before 
transplantation may regulate the transplanted 
cells differentiation in the damaged areas and 
lower the risk of malignant transformation 
compared to actively dividing precursors [26, 
64-66].
There are several methods to induce differenti-
ation of MSCs into neural cells, but, most of 
them use exogenous substances that pose cer-
tain risks, thus researchers have searched for 
inducers that are close to the natural niche of 
the human body. Cerebrospinal fluid (CSF) is 
the best candidate (Ge et al. 2015) as human 
CSF contains sufficient components and pro-
vides a physiological microenvironment suit-
able for induction of MSCs to differentiate into 
NSCs [60]. 
In our present work, we aimed to produce xeno-
free/species-specific neural and/or glial differ-
entiation media via replacement of an exoge-
nous neural inducer substance with CSF and by 
replacement of the xenogeneic FBS by one of 
the platelet-rich blood derivative formulations.
Material and methods
Isolation of MSCs from adipose tissue in the 
presence of FBS 
In a sterile biological safety cabinet, a lipoaspi-
rate sample was taken from a 23-year-old wom-
an’s brachium. It was transferred from the 
syringe to a sterile bottle and digested with 
0.075% collagenase type 1 (17018-029, Gibco) 
with shaking at 37°C for 45 minutes. Next the 
bottle content was transferred into 2 Falcon 
tubes containing 10 ml of complete media to 
neutralize enzymatic activity of the collage-
nase, containing 90% DMEM-F12 (BE04-687Q, 
Lonza), 10% FBS (fetal bovine serum) (Cat. 
10270, Gibco) and 1% Penicillin/Streptomycin/
Amphotericin B (Cat. 17-745E, BioWhittaker, 
Lonza) [63]. The tubes were centrifuged at 
1800 rpm/5 minutes; the resulting superna-
tant (oil + fat + collagenase) was discarded and 
10 ml of complete media was added to the 
resultant stromal vascular fraction (SVF). The 
tubes were centrifuged again at 1800 rpm/5 
min. Next 20 ml of complete media was added 
to each resultant pellet (after removal of the 
supernatant). The pellets were then transferred 
into 75 cm2 tissue culture flasks and incubated 
for 3 days in a CO2 incubator at 37°C and 5% 
CO2.
MSCs culture
Every 3 days, old complete media was removed 
and replaced with 20 ml new complete media. 
The flasks were observed daily with an inverted 
microscope until the cells reached 90% conflu-
ence, as determined by visual observation. 
When the percentage of the attached cells on 
the plastic surface of the tissue culture flask 
was nearly 90%, cells were subcultured from 
each original flask into 2 flasks. In this state, 
cells were designated as passage one (P1). 
During the trypsinization process, the old media 
was removed and replaced by 10 ml phosphate 
buffer saline (PBS) (Cat. BE17-516F, BioWhi- 
ttaker, Lonza) for about 30 seconds then the 
PBS was removed. After that, 10 ml of pre-
warmed trypsin/EDTA solution (Cat. BE17-16 
1E, BioWhittaker, Lonza) was added and the 
flasks were checked with an inverted micro-
scope until the cells were seen to be separated 
from each other but still attached to the flask. 
At that stage the shape of the cells changed 
from the spindle shape to spherical. The trypsin 
was removed and the cells were incubated in a 
CO2 incubator for about 2 minutes during which 
complete separation of cells occurred. After 
that, 40 ml of complete media was added to 
stop the trypsin effect. Cells were divided into 2 
new flasks, each containing 20 ml of complete 
media, and then incubated in the humidified 
incubator at 37°C and 5% CO2. The culture of 
the cells was continued untill passage 3 (P3) at 
which, the isolated MSCs were characterized 
using flow cytometer analysis (Soleimani and 
Nadri 2009).
Flow cytometry
To confirm that isolated cells were MSCs, flow 
cytometry was performed for CD90, a marker 
positive for mesenchymal stem cells and CD45, 
one which is negative for mesenchymal stem 
cells but positive for hematopoietic cells.
Cells in P3 after trypsinization were washed 
twice in PBS containing 1% bovine serum albu-
min. The cells were then stained with anti-
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CD90-FITC and anti-CD45-FITC (all purchased 
from BD Biosciences, USA) and incubated at 
room temperature for 30 minutes in the dark. 
After that, cells were washed with 2 ml of PBS/
BSA, centrifuged at 1500 rpm for 5 minutes 
and the resulting supernatant was discarded. 
Cells were resuspended in 0.4 ml of 1% para-
formaldehyde in PBS for fixation until acquiring 
the sample on the flow cytometer. The data 
were acquired and analyzed with a BD Accuri 
C6 flow cytometer). 
Preparation of activated pure PRP (P-PRP)
Whole blood from three different donors was 
collected in PRP tubes containing Na citrate. 
The tubes were centrifuged at 1200 rpm/10 
minutes (160 × g/10 minutes) and the resul-
tant plasma was transferred into new tubes 
lacking anticoagulant, avoiding buffy coat and 
erythrocyte contamination. A second centrifu-
gation step was performed at 1500 rpm/15 
minutes (250 × g/15 minutes). After the sec-
ond centrifugation the upper two-thirds con-
taining PPP (platelet poor plasma) was discard-
ed and the lower third containing PRP (platelet-
rich plasma) was collected [59].
After that, PRP was activated via the addition of 
calcium chloride at a dose of 3.4 mg/ml in a 
glass tube which was left in the incubator [54] 
for 10 minutes after which the whole PRP 
turned into a gel. The formed gel was allowed to 
stand for 4 hrs, then compressed; the resultant 
solution was centrifuged at 14799 rpm/10 min-
utes (16160 × g/10 minutes). The supernatant 
collected was activated PRP, concentrated at 
100%. From this other concentrations were 
prepared by serial dilutions for the proliferation 
assay. To collect a large volume of PRP, whole 
blood was collected from 3 different donors; 
about 500 ml blood from each one was collect-
ed into a triple blood bag for PRP preparation 
and activation as discussed previously.
It was noted that if PRP were added directly to 
culture media, without the activation process, 
the platelets would chelate thanks to the calci-
um present in the media; which would then 
change from a liquid form into a gel which would 
not be useful. Chelation depends on the per-
centage of Ca2+ present in the media. We found 
that: PRP + DMEM low glucose Sigma = some 
gel fragments in the whole volume. PRP + 
DMEM low glucose Lonza = No gel. PRP + 
DMEM high glucose Lonza = some gel 
fragments in the whole volume. PRP + Hams/
F12 Lonza = No gel. PRP + DMEM high glucose 
+ Hams/F12 Lonza = No gel.
Preparation of A-PRF
From the same three donors of PRP, approxi-
mately 10 ml of whole blood each was collect-
ed in 3 vacuum glass tubes without anticoagu-
lant for A-PRF preparation.
The tubes were centrifuged at 1500 rpm/14 
minutes [25] after which the formed gel was 
collected using surgical tweezers and separat-
ed from the lower layer rich in red blood cells. 
Thus most RBCs were removed to avoid precipi-
tation of RBCs in the culture, which would pro-
duce a false result. The gel was then com-
pressed [46] resulting in A-PRF exudates and 
A-PRF membrane; A-PRF exudates were col-
lected for the experiment while the remaining 
PRF membrane was discarded. The exudates 
were centrifuged at 14799 rpm/10 minutes 
(16160 × g/10 minutes) to precipitate RBCs. 
The resultant supernatant collected and stored 
at -20°C until use. 
Cell proliferation assay
AD-MSCs were seeded at a density of 3000 
cells/well in 96-well culture plates in complete 
media (with 10% FBS) until the next day. Then 
the complete media was replaced with serum-
free media (0% FBS) for 4 hrs. The serum-free 
media was replaced with different concentra-
tions of activated PRP and advanced PRF: 20, 
10, 5, 2.5, 1.25, 0.6% in serum-free media. 
10% FBS was used as a control. Each concen-
tration was duplicated for each donor.
After 3 and 5 days, the proliferation rate was 
evaluated using the MTT assay according to the 
manufacturer’s instructions. MTT measures 
the metabolic activity of mitochondrial enzymes 
of the cultured cells. Tetrazolium salts were 
transformed into visible dark blue formazan 
deposits using cellular mitochondrial dehydro-
genase. The amount of color produced was 
directly proportional to the number of viable 
cells [50]. The plates were read by an ELISA 
reader (BioTek, made in USA, SN 269050) at 
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490 and 630 nm wavelengths and the mean 
was taken.
Differentiation of MSC into neuronal and glial 
cells
At P3 MSCs were trypsinized and one million 
cells were collected as a control for RNA extrac-
tion and gene expression (undifferentiated 
MSCs with 20% PRP). Then small numbers of 
cells (30,000 cells) were seeded with culture 
media containing 10% PRP in each 25 cm2 tis-
sue culture flask. The next day, we added CSF 
to the culture media at different concentra-
tions. The media were changed every day for 8 
days and on the 9th day, all cells were collected 
for RNA extraction and gene expression. The 
groups (G) used were: G1 (the control group col-
lected during the proliferation stage with 20% 
PRP just before starting the differentiation 
stage and considered as day 0), G2 (0% CSF + 
10% PRP in DMEM F-12), G3 (0.5% CSF + 10% 
PRP in DMEM F-12), G4 (2.5% CSF + 10% PRP 
in DMEM F-12), G5 (5% CSF + 10% PRP in 
DMEM F-12) and G6 (10% CSF + 10% PRP in 
DMEM F-12). CSF was collected by lumbar 
puncture of a 31 year-old woman suffering from 
benign intracranial hypertension (BIH) syn-
drome. BIH or pseudotumor cerebri is defined 
by increased intracranial pressure, an absence 
of ventriculomegaly, no evidence of intracranial 
extensive lesion and normal CSF composition 
[55]. Once CSF was drawn, it was transported 
into the lab quickly and filtered with 0.2 µm 
syringe filter in a safety cabinet to sterilize the 
sample from any contaminants, which might 
have been introduced during collection. The 
CSF was then aliquoted into sterile vials and 
stored in -20°C until use.
RNA extraction and RT-PCR
Real time-PCR was performed for Nestin, a 
neural progenitor marker; for microtubule-as- 
sociated protein 2 (MAP2), a mature neuronal 
marker; and for glial fibrillary acidic protein 
(GFAP), a mature astrocyte marker. 
The first RNA preparation was performed be- 
fore the induction of the cell differentiation as 
a control sample; and at the 9th day of diffe- 
rentiation, using Direct-zolTM RNA MiniPrep (Cat. 
R2050, USA) according to the manufacturer’s 
instructions. The extracted RNA’s concentra-
tion was measured with a NanoDrop™ 2000 
(Spectrophotometers; Thermo Scientific, USA). 
cDNA was synthesized from total RNA using 
the High-Capacity cDNA Reverse Transcription 
Kits according to the manufacturer’s instruc-
tions. Finally, Real time-PCR with SYBR Green 
was used to measure the expression of mRNA 
of  target genes, with GAPDH as an internal 
reference using HERA SYBR Master Mix 2x 
(WF1030400X) following the manufacturer’s 
protocol. The primers used in the amplification 
are shown in Table 1. 
Statistical analysis
Using GraphPad Prism 6.0 (GraphPad Soft- 
ware, Inc., La Jolla, CA, USA), means and SD 
were calculated from triplicates. The relative 
fold of change of gene expression was deter-
mined using a one-way analysis of variance 
(ANOVA) followed by Dunnett’s post hoc test. 
Data obtained were compared to the control, 
and P ≤ 0.05 was considered significant.
Results
Characterization of MSC cultured with 10% 
FBS
Morphological analysis: On the 3rd day of isola-
tion, small spindle-shaped MSCs started to 
appear with confluence of about 40%. They 
adhered to the plastic surface of the flask with 
large numbers of non-MSCs present. On the 
6th day, the number of cells increased, and the 
cells became larger and more spindle-shaped. 
From the 2nd feed until passage 1 (P1) MSCs 
Table 1. Forward and reverse primers sequence for candidate genes
Gene Forward Reverse Anneal.Temp. Product length
MAP2 CCAATGGATTCCCATACAGG TCTCCGTTGATCCCATTCTC 56°C 100
Nestin GAGCAGGAGGAGTTGGGTTC TCCTCGCTCTCTTCTCTGCT 56°C 80
GFAP AGATCCACGAGGAGGAGGTT ATACTGCGTGCGGATCTCTT 65°C 122
GAPDH CCACCACACTGAATCTCCCC TGGTACATGACAAGGTGCGG 56°C 90
Xeno-free adipose tissue-derived mesenchymal stem cells
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proliferated more and more, reaching a conflu-
ence of 90%, at which point subculture was 
necessary. Culture continued until P3 and with 
each feeding and passage process the number 
of non-MSCs decreased and MSCs increased, 
with the culture becoming more pure (Figure 
1C-E). The morphological change was the same 
as those of cells isolated and cultured with 
20% activated P-PRP (Figure 1F-H).
Flow cytometry analysis: Flow cytometry re- 
vealed that MSCs were positive for CD90, 
which is highly expressed in 74.9% of the cells 
(Figure 1). In contrast, CD45, a negative mark-
er for MSCs and positive marker for hematopoi-
etic cells, was expressed in only 5.6% of the 
cells (Figure 1). 
Cell proliferation assay
The results of MTT assay demonstrate that the 
addition of 20% of activated P-PRP induces a 
higher proliferation rate of AD-MSCs in compar-
ison to P-PRP or 10% FBS either at 3 or 5 days. 
20% of A-PRF induced a higher proliferation 
rate of AD-MSCs than 10% FBS either at 3 or 5 
Figure 1. Analysis of undifferentiated AD-MSCs cultured with 10% FBS, 20% PRP and the 1st day after culturing 
with 10% PRP just before addition of CSF for differentiation induction. (A, B) Flow cytometry analysis showed that 
74.9% of AD-MSCs were positive for CD90 (A) and only 5.6% for CD45 (hematopoietic marker). Other images repre-
sent the morphological analysis via inverted phase contrast microscope. (C, F) represent day 1 of isolation showing 
SVF containing a heterogeneous type of spherical cells suspended in the media. (D, G) represent day 6 of isolation 
showing spindle-shaped MSCs attached to the plastic surface of the flask. (E, H) showed spindle-shaped MSCs with 
a high density just before P3 with 4x magnification) while (I-K) show AD-MSCs after incubation with only 10% PRP 
for 24 hr. Before addition of CSF showing different morphological changes, some cells are polygonal shaped with 
astrocyte-like morphology (I), some other cells start to take tapered shape (J) and others still showed spindle shape 
(K) with 10x magnification. 
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days; while 10% A-PRF showed no difference at 
3 days and slightly lower than FBS at 5 days. 
20% of activated P-PRP increased the prolifera-
tion rate significantly over 10% A-PRF (Tables 2 
and 3).
Characterization of neuronal/glial cells
Inverted phase contrast microscopic of AD- 
MSCs incubated at different time points with 
different concentrations of CSF and PRP (Figure 
2) revealed the presence of neural-like cells. 
These cells were much pronounced in in pres-
ence of 0.5% CSF + 10% PRP at different time 
points.
Morphological analysis of differentiated cells: 
On the first day (after incubation of cells in only 
10% PRP for 24 hr just before addition of CSF), 
some cells still showed a spindle shape, while 
other cells started to take tapered, triangular or 
pyramidal shapes, with some displaying poly- 
gonal shapes with astrocyte-like morphology 
(Figure 3). Small numbers of processes devel-
oped from some cells. From the 2nd day until 
the 9th day in all groups, cell numbers increas- 
at the cells moved to a differentiation stage 
(Figure 3C). MAP2 gene expression was up-reg-
ulated in the 0% CSF + 10% PRP group, indicat-
ing that the decrease of PRP in the culture from 
20% to 10% was associated with an increase 
of neuronal differentiation (Figure 3A). Finally, 
GFAP gene expression was down-regulated in 
comparison to the control group and other 
groups with the exception of 10% CSF + 10% 
PRP group in which it was up-regulated, indicat-
ing glial differentiation (Figure 3B).
Discussion
There are criteria which must be taken into con-
sideration for stem cells to have clinical appli-
cation. Supplements used for either prolifera-
tion or differentiation must be xeno-free in 
order to avoid immune rejection after trans-
plantation. Also, stem cells must proliferate in 
sufficient numbers to meet the demands of 
clinical transplantation [29].
Our study aimed to produce xeno-free autolo-
gous or allogenic neural lineage differentiation 
Table 2. Table shows the means of cell viability (%) as measured by 
ELISA reader after culturing in 96-well plate with activated PRP and 
A-PRF at different concentrations and 10% FBS as a control for three 
days
3 day
A-PRF A-PRF A-PRF PRP PRP PRP
10% FBS
Donor A Donor B Donor C Donor A Donor B Donor C
20% 140.7% 125.1% 131.6% 163.8% 148.9% 156.1%
10% 103% 101.4% 99.2% 146.9% 119.4% 99.2% 100%
5% 86.9% 89.9% 86.3% 114.6% 95.6% 93.5%
2.5% 85.3% 87.7% 79.8% 96.9% 84.17% 82.1%
1.25% 85.3% 83.4% 79.1% 89.2% 76.9% 75.5%
0.6% 86.9% 82.7% 74.8% 94.6% 71.2% 59.7%
ed day after day until reach-
ing high confluence on the 
9th day, at which point 
extraction of RNA was per-
formed. There was no ch- 
ange of cell morphology 
among all groups with the 
exception of G1 (control). 
Some cells showed neural-
like shapes with a long pro-
cess on one side (axon-like) 
and processes from other 
sides (dendrite-like). Some 
cells showed a polygonal 
shaped body with short pro-
cesses, similar to astrocy- 
te-like morphology. Starting 
from the 7th up to the 9th 
day the cell morphology be- 
came less distinct with in- 
creasing cell numbers (Fi- 
gure 3).
RT-PCR analysis: The Nestin 
gene expression was maxi-
mum in the control group 
(20% PRP) compared to 
other groups in which the 
expression levels were do- 
wn-regulated, suggesting th- 
Table 3. Table for the means of cell viability (%) as measured by 
ELISA reader after culturing in 96-well plate with activated PRP and 
A-PRF at different concentrations and 10% FBS as a control for five 
days
5 day
A-PRF A-PRF A-PRF PRP PRP PRP
10% FBS
Donor A Donor B Donor C Donor A Donor B Donor C
20% 169% 114.7% 124.7% 278.1% 167.8% 199%
10% 107.7% 83.6% 89.6% 193.6% 107.3% 99% 100%
5% 88% 76.3% 80.1% 118.3% 86.3% 84.1%
2.5% 85.2% 74.7% 68.8% 102.1% 74.2% 79.7%
1.25% 88.7% 72.1% 65.8% 87.3% 62.1% 74.2%
0.6% 84.5% 67.8% 77.2% 95.7% 58.4% 67.3%
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media. Thus we focused on 2 important points; 
first, the replacement of FBS with a xeno-free 
product during the proliferation stage; and sec-
ond, producing differentiation media (neural/
glial) from a xeno-free product to mimic the 
natural niche.
Proliferation analysis
FBS is the proliferative source for MSC but it is 
not the best choice for clinical applications 
despite its acceptable results. This may be due 
to its xenogeneic source, which increases the 
risk of transmitting an infectious agent, as well 
as immunogenic problems. So many studies 
have been focused on the usage of different 
blood concentration products such as PRP and 
and we found that 10 or 20% activated P-PRP 
is more potent than 10 or 20% A-PRF res- 
pectively.
Our results agree with most studies that report 
that PRP induces cell proliferation, but the best 
concentration that exerts the best effect varies 
from one study to another.
Tavakolinejad et al. tested the effect of 10 and 
15% human PRP (hPRP) on AD-MSC compared 
to 10% FBS [51] and it was reported that 15% 
hPRP was the most potent supplement for pro-
moting hAD-MSCs proliferation, followed by 
10% hPRP and 10% FBS. Also [42, 57] reported 
that 15% PRP and 20% PRP stimulated AD- 
MSCs proliferation with no significant differ-
ence between them, so they concluded that 
Figure 2. Inverted phase contrast microscopic images (A-D) of AD-MSCs in-
cubated at different time points with 5% CSF + 10% PRP; 2.5% CSF + 10% 
PRP (E-H). (I-L) Some cells show neural-like morphology in presence of 0.5% 
CSF + 10% PRP at different time points.
PRF as a substitute for FBS in 
various types of cell cultures.
Both PRP and PRF have re- 
vealed promising but confus-
ing results in various stem-
cell-based tissue engineering 
and regenerative medicine 
applications (Masoudi et al. 
2017). A-PRF is a modified 
form of PRF which releases 
significantly more growth fac-
tor over time compared to 
standard PRF [25]. Thus, we 
focused on P-PRP (specifical- 
ly activated pure PRP) and 
A-PRF as substitutes for FBS 
and tested their effect on 
AD-MSCs proliferation.
Our results show that both 
activated P-PRP and A-PRF 
are good inducers for AD- 
MSCs proliferation and that 
20% P-PRP and 20% A-PRF 
are more potent than 10% 
FBS in all donors either after 
3 or 5 days. While 10% con-
centration varied between dif-
ferent donors, for activated 
P-PRP the 10% was nearly si- 
milar or slightly higher than 
10% FBS; while for A-PRF, the 
10% was nearly similar or 
slightly lower than 10% FBS. 
Also when compared between 
activated P-PRP and A-PRF 
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15% PRP was the optimal concentration for the 
proliferation of AD-MSCs.
Our previous results are in conflict with other 
papers. For example, [1] reported that 10% PRP 
induced a higher proliferation effect on human 
adipose tissue, bone marrow (BM) and Wharton 
jelly, but more than 10% of PRP inhibited cell 
growth. Others (Kakudo et al. 2008) reported 
that the maximum promotion of AD-MSCs pro-
liferation was exerted by 5% of activated PRP, 
but that 20% did not promote. Also, [32] (Van 
Pham et al., 2014) reported that 5% PRP is 
sufficient to significantly enhance AD-MSCs 
proliferation.
Furthermore [26] reported that 1% PRP stimu-
lated cell proliferation to a great extent but th- 
at 3% and 5% PRP decreased  proliferation in 
comparison to 1% PRP. [7] found that PRP 
enhanced AD-MSCs proliferation in a dose-
dependent manner from up to 50%.
Figure 3. Analysis of AD-MSCs induced to differentiation. (A-C) are graphical representation of real-time quantitative 
PCR analysis of MAP2 (A), GFAP (B) and Nestin (C) genes expression showing significant increase of MAP2 with 0% 
CSF + 10% PRP indicating neural differentiation and significant increase of GFAP with 10% CSF + 10% PRP indi-
cating glial differentiation while Nestin is significantly decreased in all groups indicating that cells are addressed 
toward differentiation. Other images represent the morphological analysis via inverted phase contrast microscope 
for AD-MSCs after incubation with 0% CSF + 10% PRP (D-I), and 10% CSF + 10% PRP (J-O) at different time points, 
some cells showing neural-like morphology (black arrow) and some others were showing astrocyte-like morphology 
(red arrow) while at 9th day the cell morphology become less distinct with high increase in the cells number. 
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Other studies have reported PRP effects on 
other types of cells. [39, 59] reported that 10% 
PRP increased rat BM-MSCs proliferation in 
comparison to FBS. [19] reported that P-PRP 
stimulated tendon stem cell (TSCs) prolifera-
tion with increasing concentrations from 2% to 
10%. [37] reported that low concentrations 
(1-5%) of PRP stimulated the proliferation rate 
of alveolar bone cells while higher concentra-
tions of PRP suppressed proliferation.
[45] reported that 2-20% PRP increased the 
proliferation rate of amniotic fluid MSC and th- 
at 10% PRP increased the proliferation rate of 
skin fibroblasts. But [16] reported that 2.5% 
activated PRP induced the maximum effect on 
fibroblasts, with higher concentrations (3.5/ 
5.5%) resulting in a reduction of cell prolifera- 
tion.
All these conflicting results may reflect the 
fact that there is no standard protocol for PRP 
preparation; or that different centrifugal speeds 
were used; also that some studies used acti-
vated PRP while others used non activated 
PRP; or that variations of the activation meth-
ods and anticoagulant types were used. Some 
papers failed to report the type of PRP used, 
whether it was L-PRP or P-PRP. This is all in 
addition to fundamental individual differences 
and the differences between the types of cells 
tested. Therefore, it is difficult to assess the 
quality of PRP preparations.
With respect to different centrifugal speeds, it 
has been demonstrated that the optimal cen-
trifugation protocol for PRP preparation is 250 
× g [2] and that more than 800 × g may 
decrease the amount of released growth factor 
[27]. For activated and non-activated PRP some 
researchers reported that activated PRP and 
activated PPP increased the proliferation rate 
of human AD-MSCs and human dermal fibro-
blasts more than non-activated PRP and non-
activated PPP. Also, they reported that activat-
ed PRP increased the proliferation rate more 
than activated PPP [24]. 
On the question of activation methodology, it 
has been reported that the amount of growth 
factors released from PRP differs according to 
the type of activation method used. PRP fac-
tors release derived from 23 mM CaCl2 activa-
tion contains 80% of the total PDGF content 
and is easily produced; also CaCl2 is an effec-
tive and inexpensive method so it is suitable for 
clinical use. Autologous thrombin induced less 
platelet growth factors release than other acti-
vation methods and significantly less platelet 
aggregation than bovine thrombin at 5 U/mL, 
Thus, autologous thrombin is not recommend-
ed for PRP activation [54].
For pure PRP and leukocyte-rich PRP, studies 
have demonstrated that P-PRP is better than 
L-PRP. This was proven when some researchers 
compared the effects of P-PRP and L-PRP on 
tendon stem cells (TSCs) and found that P-PRP 
stimulated the growth more than L-PRP. Also, it 
has been reported that L-PRP inhibited the pro-
liferation of TSCs in a concentration-dependent 
manner [19]. Other studies have tested the 
effect of P-PRP and L-PRP on rat BM-MSCs and 
demonstrated that the L-PRP group had fewer 
cells than the P-PRP group after 5 and 7 days 
of culture, reflecting the harmful effects of 
TNF-α and IL-1β that are present in L-PRP in an 
amount higher than P-PRP [59].
PRF is another blood concentration product, 
which can simplify the preparation procedure 
of PRP. It is prepared simply without anticoagu-
lant, with only one centrifugation step, and 
needs no chemical additives to make a gel. 
Clinical results appeared to have fewer contro-
versial aspects when compared to PRP [56].
The modified form of PRF called A-PRF is ex- 
pected to contain  relatively higher numbers of 
white blood cells (WBC) [38], platelets [15] and 
higher total quantities of growth factors com-
pared to traditional PRF. Also, because of low-
speed centrifugation, A-PRF fibrin clot is softer 
than that of the original PRF [25].
So, in our study, we tested the effect of A-PRF 
on AD-MSCs proliferation and found that 20% 
A-PRF increases the proliferation rate more 
than 10% FBS. Masuki et al. reported that 
A-PRF stimulated human periosteal cell prolif-
eration in a dose-dependent manner (0.625-
10%) [38]. Margono et al. reported that 12.5 
and 25% A-PRF increased fibroblast prolifera-
tion rate and 12.5 A-PRF increased fibroblast 
proliferation rate more than 25% [36]. 
This implies that FBS can be replaced by 10% 
or 20% activated PRP or 20% A-PRF to stimu-
late AD-MSCs proliferation and that will all 
increase the proliferation rate, with 20% acti-
vated PRP giving the best effect.
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This is partially in agreement with [38] who 
reported that PRP is more potent than A-PRF 
on human periosteal cell proliferation; but they 
also reported that maximal effect of PRP was 
observed at 2.5%, while A-PRF stimulated cell 
proliferation in a dose-dependent manner 
(0.625-10%). These investigators also reported 
that both A-PRF preparations contained TGF-
β1, PDGF-BB, VEGF, IL-1β, and IL-6 at levels 
similar to or higher than PRP preparations.
This is similar to the report of [56] who noted 
that the potency on cell proliferation of PRP is 
higher than PRF, and other scientists who have 
reported that A-PRF released significantly high-
er total quantities of growth factors compared 
to traditional PRF. This means that the amount 
of growth factor in A-PRF is more than that of 
PRP [25].
Differentiation analysis
Disorders related to the nervous system are 
among the most critical problems that end with 
severe complications and disability. Stem cell 
therapy is one of the most important strategies 
for these patients, to solve special problems 
via use of allogeneic cells and differentia tion of 
cells into active nerve cells [41, 40, 53].
There are several protocols to induce the dif-
ferentiation of MSCs into neural cells including 
exposure of cells to cytokines [19]; chemical 
induction [22]; and therapeutic gene transfec-
tion [33]. Tissue regeneration is a complex pro-
cess driven by a cascade of factors. Use of only 
a single factor usually is not sufficient to pro-
duce the needed therapeutic effects. The use 
of a natural reservoir of growth factors would 
have a better effect than the use of a single 
growth factor [30, 31].
PRP is a natural reservoir of numerous growth 
factors, including NGF, BDNF, PDGF, VEGF, IGF-
1, and TGF-β, which exert neuroprotective and 
antiapoptotic effect on MSCs, neurons, SCs, 
and human NSC [3, 9, 28, 34, 44, 49]. 
CSF is another natural reservoir of several 
growth factors, such as bFGF, BDNF and GDNF 
(glial cell-derived neurotrophic factor) [17, 20]. 
It has been reported that macro-molecules 
available in CSF lead to the formation of a sig-
nal cascade altering the expression of tran-
scription factors and genes, impacting some of 
the vital functions of cells [18].
Based on previous published data, we expect-
ed that the combination of PRP (as an alterna-
tive to FBS) and CSF would be a potent neural 
and/or glial differentiation factor and that it 
improve results over those of previous studies. 
We chose different concentrations of CSF rang-
ing from 0.5% to 10% (the most common range 
of concentrations mentioned in previous stud-
ies), and we decreased the percentage of PRP 
from 20% at the proliferation stage to 10% at 
differentiation stage to allow as long as differ-
entiation period as possible to avoid rapid con-
fluence of the cells in the flask. This was 
because both PRP and CSF increased prolifera-
tion rate. In fact, we found unexpected results 
when PRP was combined with CSF; the expres-
sion of Nestin and MAP2 were downregulated 
in groups with different concentrations of CSF 
compared to the control sample (AD-MSCs at 
proliferation stage with 20% PRP). At the same 
time expression of GFAP was only upregulated 
in combination with 10% CSF and 10% PRP 
indicating glial differentiation. Cells cultured for 
9 days with only 10% PRP showed the expres-
sion of MAP2 increased indicating a neurogenic 
differentiation, while Nestin and GFAP were 
downregulated in the same culture conditions 
compared to control group.
This indicated that the combination of CSF and 
PRP inhibited neuronal differentiation and stim-
ulated glial differentiation. The change in the 
percentage of PRP has the ability to stimulate 
neuronal differentiation.
Our finding of inhibitory effects of CSF on neu-
rogenesis and  promoting effects on astroglio-
genesis is in agreement with the results of [35] 
and [5] who tested the effect of adult human 
CSF on rat fetal NSCs; and with those of [4] on 
adult human NSCs. All these investigators dem-
onstrated that CSF stimulates the differentia-
tion toward glial cells, not in neuronal cells.
But [60] who tested the effect of human adult 
healthy CSF on rat BM reported that cells were 
positive for both neuronal specific enolase 
(NSE, neuronal marker) and GFAP, and the 
expression levels for NSE were higher than 
GFAP. Others [47] tested the effect of rat 
embryonic CSF (E-CSF) on rat BM-MSCs report-
ed that CSF can induce proliferation and neural 
differentiation of BM-MSCs in an age-depen-
dent manner. [61] tested the effect of adult 
CSF on human BM-MSCs and reported that 
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CSF effects MSC differentiation in neural-like 
cells. [12] tested the effect of normal child CSF 
on WJ-MSCs, showing that CSF could play a role 
as a strong inducer in dose-dependent and 
time-dependent manners for Nestin, GFAP, and 
MAP2. [41] concluded that rabbit CSF induc- 
ed rabbit BM-MSCs to transdifferentiate into 
neuronal cells and glial cells (astrocytes and 
Oligodendrocytes). [18] tested the effect of 
newborn rat CSF on trans-differentiation of 
human dental pulp stem cells (hDPSCs).
We can draw some conclusions that the varia-
tion of the results depends on the source of the 
MSCs and/or CSF and the variation is dose and 
time dependent. In addition, the age of donor 
(adult, child or embryonic) from which CSF is 
obtained can affect the results.
Our results showed PRP as an inducer of neuro-
genesis. This is in agreement with (Hongmian Li 
et al. 2013) who reported that 10% PRP is a 
promoter for human AD-MSCs proliferation and 
neurogenic differentiation in vitro. Finally, PRP 
alone can induce neural differentiation at 10% 
for 9 days; 10% CSF in combination with 10% 
PRP induce glial differentiation. 
Further studies need to be performed to un- 
derstand the mechanisms of the neural inhibi-
tion by CSF, but this may be explained as fol-
lows: 1) both of CSF and PRP are rich in differ-
ent growth factors, and their combination may 
result in a new inhibitory complex; 2) the time 
of exposure of cells to CSF is very critical and 
maybe early or late collection of cells may 
affect differently the results. Also [61] report- 
ed that CSF contains one or more factors that 
inhibit differentiation into neural-like cells after 
a finite period in culture; 3) it is possible that 
another type of neuronal lineage would be ex- 
pressed if we increased the investigated mar- 
kers.
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